Brooks et al. 2026 (young adult)

Leveraging real-world data to create vancomycin population pharmacokinetic models in younger adults and patients with low serum creatinine

Journal of the American Pharmacists Association Pharmacotherapy · 10.1016/j.japhar.2025.100026

Structure

A two-compartment model, driven by weight, age, sex and serum creatinine.

Study population

General patients — United States and North America. Fitted to 6,080 patients and 19,071 concentration observations.

Covariate As reported
Age 30 (18–35) yr
Weight 78 (39–210) kg
BMI 27 (15–69) kg/m²
CrCl 150 (32–470) mL/min
SCr 0.8 (0.28–3.3) mg/dL

Reported as the source publication gives them — mean ± SD, or median with range or interquartile range.

Equations

The model's structural parameters as Chorus implements them.

CL=4.2622(FFM55)0.2742(eGFRabs100)0.9452CL = 4.2622 \cdot \left(\frac{FFM}{55}\right)^{0.2742} \cdot \left(\frac{eGFR_{abs}}{100}\right)^{0.9452}eGFRabs=eGFRCKDEPIBSADuBois1.73eGFR_{abs} = eGFR_{CKD-EPI} \cdot \frac{BSA_{DuBois}}{1.73}V1=40.7349FFM55V_1 = 40.7349 \cdot \frac{FFM}{55}V2=48.7348FFM55V_2 = 48.7348 \cdot \frac{FFM}{55}Q=2.9295(FFM55)0.2742Q = 2.9295 \cdot \left(\frac{FFM}{55}\right)^{0.2742}
LaTeX source
CL = 4.2622 \cdot \left(\frac{FFM}{55}\right)^{0.2742} \cdot \left(\frac{eGFR_{abs}}{100}\right)^{0.9452}
eGFR_{abs} = eGFR_{CKD-EPI} \cdot \frac{BSA_{DuBois}}{1.73}
V_1 = 40.7349 \cdot \frac{FFM}{55}
V_2 = 48.7348 \cdot \frac{FFM}{55}
Q = 2.9295 \cdot \left(\frac{FFM}{55}\right)^{0.2742}

Implementation notes

Young adult model (18-35). Uses Janmahasatian FFM normalized to 55 kg (not the 50 kg printed in Table 2 — author-confirmed erratum) and CKD-EPI 2021 eGFR de-indexed to absolute mL/min via Du Bois BSA.

Simulation settings

Models

selected

Dose candidates (mg)

Interval candidates (h)

Demographics

Physical characteristics.

kg
cm
yr